DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Keppra (Levetiracetam) - Condition Aggravated - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Condition Aggravated ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Keppra (Levetiracetam) where reactions include condition aggravated. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Keppra side effects in 18 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08

Patient: 18 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Drug Interaction, Condition Aggravated, Convulsion

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 200 mg;bid;po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-11-01

Keppra
    Indication: Product Used FOR Unknown Indication

Nexplanon
    Dosage: 68 mg;sbde
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-01

Other drugs received by patient: Doxycycline; Loratadine



Possible Keppra side effects in 18 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-07

Patient: 18 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Condition Aggravated, Drug Interaction, Convulsion

Drug(s) suspected as cause:
Nexplanon
    Dosage: 68 mg, subdermal
    Indication: Contraception
    Start date: 2011-03-01

Lamotrigine
    Dosage: 200 mg, 2 in 1 d, oral
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2010-11-01

Keppra
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Doxycycline; Loratadine



Possible Keppra side effects in 85 year old male

Reported by a pharmacist from United States on 2012-05-01

Patient: 85 year old male, weighing 77.2 kg (169.8 pounds)

Reactions: Acute Sinusitis, Dementia, Encephalopathy, Condition Aggravated

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Keppra
    Dosage: 280mg x 3 day qhs po recent
    Administration route: Oral
    Indication: Convulsion

Prednisone
    Dosage: recent
    Indication: Pneumonia

Levaquin
    Dosage: recent
    Indication: Pneumonia

Other drugs received by patient: Simvastatin; Etodolac; Altace; Ultram; Donepezil HCL; Uloric; Risperdal; Namenda



Possible Keppra side effects in 18 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-24

Patient: 18 year old female

Reactions: Condition Aggravated, Drug Interaction, Convulsion

Drug(s) suspected as cause:
Nexplanon
    Dosage: 69 mg, subdemal
    Indication: Contraception
    Start date: 2011-03-01

Keppra
    Indication: Product Used FOR Unknown Indication

Lamotrigine
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Loratadine



Possible Keppra side effects in female

Reported by a individual with unspecified qualification from United States on 2012-02-03

Patient: female, weighing 53.2 kg (117.0 pounds)

Reactions: Pain, Nocturia, Headache, Hot Flush, Unevaluable Event, Tearfulness, Product Quality Issue, Drug Effect Decreased, Condition Aggravated, Cognitive Disorder, Amnesia, Negativism, Apathy, Irritability, Affect Lability, Dependence, Sleep Disorder, Activities of Daily Living Impaired, Sinus Headache, Disturbance in Attention, Ear Pain

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Keppra
    Dosage: 250mg keppra 2x/day oral, pill no other treatment since may 2009
    Administration route: Oral
    Indication: Brain Neoplasm Malignant
    Start date: 2009-12-01

Keppra
    Dosage: 250mg keppra 2x/day oral, pill no other treatment since may 2009
    Administration route: Oral
    Indication: Anaplastic Astrocytoma
    Start date: 2009-12-01

Keppra
    Dosage: 250mg keppra 2x/day oral, pill no other treatment since may 2009
    Administration route: Oral
    Indication: Convulsion
    Start date: 2009-12-01



Possible Keppra side effects in 53 year old male

Reported by a physician from France on 2012-02-03

Patient: 53 year old male

Reactions: Anaemia, Condition Aggravated, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aranesp
    Dosage: 50 mug, q2wk
    Indication: Product Used FOR Unknown Indication

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Start date: 2011-05-01

Keppra

Eupressyl
    Dosage: 90 mg, qd
    Administration route: Oral
    Start date: 2011-05-29

Kayexalate
    Dosage: 15 g, 3 times/wk
    Administration route: Oral
    Start date: 2011-06-03

Citalopram Hydrobromide
    Dosage: 20 unk, unk
    Administration route: Oral

Calcium Carbonate
    Dosage: unk
    Administration route: Oral

Renagel
    Dosage: unk unk, qd
    Administration route: Oral



Possible Keppra side effects in 24 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-30

Patient: 24 year old female

Reactions: Condition Aggravated

Drug(s) suspected as cause:
Topamax
    Dosage: (175 mg, 75 mg in am+100mg at bedtime oral)
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-01

Suboxone
    Dosage: (12 mg, daily dose: 12mg; cuts an 8mg strip to achieve dose sublingual)
    Indication: Drug Dependence
    Start date: 2011-07-01

Keppra
    Dosage: (1000 mg, daily dose: 100mg oral)
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-01

Other drugs received by patient: Phenobarbital TAB



Possible Keppra side effects in 17 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09

Patient: 17 year old female

Reactions: Multi-Organ Failure, Agranulocytosis, Histiocytosis Haematophagic, Condition Aggravated, Pancytopenia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Keppra
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-06

Sufenta Preservative Free
    Dosage: unk
    Indication: Sedation
    Start date: 2008-11-29
    End date: 2008-12-25

Urbanyl
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-15

Cyclophosphamide
    Dosage: 750.0 mg, 1x/cyc
    Indication: Sjogren's Syndrome
    Start date: 2008-12-25

Phenobarbital TAB
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-01

Pentothal
    Dosage: unk
    Indication: Sedation
    Start date: 2008-12-08

Vancomycin HCL
    Dosage: unk
    Indication: Pneumonia Staphylococcal
    Start date: 2008-12-01

Piperacillin and Tazobactam
    Dosage: unk
    Indication: Escherichia Bacteraemia
    Start date: 2008-12-25

Pantoprazole Sodium
    Dosage: unk
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2008-12-01

Diprivan
    Dosage: unk
    Indication: Sedation
    Start date: 2008-12-18

Depakene
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-26

Amikacin
    Dosage: unk
    Indication: Escherichia Bacteraemia
    Start date: 2008-12-25

Fosphenytoin Sodium
    Dosage: unk
    Indication: Status Epilepticus
    Start date: 2008-12-09
    End date: 2008-12-01

Other drugs received by patient: Paracetamol; Neostigmine; Duphalac; Solu-Medrol; Norepinephrine; Neupogen



Possible Keppra side effects in 53 year old male

Reported by a physician from France on 2011-12-29

Patient: 53 year old male

Reactions: Anaemia, Condition Aggravated, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Citalopram Basics
    Dosage: 20 unk, unk
    Administration route: Oral

Prednisone TAB
    Dosage: 30 mg/kg, qd
    Administration route: Oral
    Start date: 2011-05-01

Keppra

Renagel
    Dosage: unk unk, qd
    Administration route: Oral

Kayexalate
    Dosage: 15 g, 3 times/wk
    Administration route: Oral
    Start date: 2011-06-03

Eupressyl / 00631801 /
    Dosage: 90 mg, qd
    Administration route: Oral
    Start date: 2011-05-29

Aranesp
    Dosage: 50 mug, q2wk
    Indication: Product Used FOR Unknown Indication

Calcium Carbonate
    Dosage: unk
    Administration route: Oral



Possible Keppra side effects in 83 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-11-25

Patient: 83 year old female

Reactions: Condition Aggravated, Cholestasis, Hepatic Cirrhosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Calciparine
    Dosage: 2 in 1 d, subcutaneous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-27
    End date: 2011-07-04

Keppra
    Dosage: 500 mg milligram(s), 2 in 1 d, intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-30
    End date: 2011-07-12

Novolog
    Dosage: 1 in 1 d, subcutaneous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-01
    End date: 2011-07-04

Onfi
    Dosage: 10 mg milligram(s), 1 in 1 d, oral
    Administration route: Oral
    Indication: Status Epilepticus
    Start date: 2011-06-27

Insulin
    Dosage: 1 in 1 d, subcutaneous
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-30
    End date: 2011-07-04

Acetaminophen
    Dosage: 1 g gram(s), 3 in 1 d, oral
    Administration route: Oral
    Indication: Pain
    Start date: 2011-07-02
    End date: 2011-07-12

Other drugs received by patient: Propranolol; Oxazepam; Lormetazepam; Mianserine (Mianserin Hydrochloride); Aldactone; Pantoprazole; Diffu K (Potassium Chloride0; Furosemide



Possible Keppra side effects in 3 year old female

Reported by a consumer/non-health professional from United States on 2011-11-15

Patient: 3 year old female, weighing 13.2 kg (29.0 pounds)

Reactions: Alopecia, Condition Aggravated, Convulsion

Drug(s) suspected as cause:
Increlex
    Dosage: 30 units (15 units, 2 in 1 d), subcutaneous
    Indication: Growth Hormone Deficiency
    Start date: 2011-03-01

Dilantin
    Dosage: 4 ml (2 ml, 2 in 1 d), other
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-01

Keppra
    Dosage: 6 ml (3 ml, 2 in 1 d), other
    Indication: Convulsion
    Start date: 2011-04-01

Other drugs received by patient: Ranitidine Hydrochloride; Phenobarbital TAB; Multivitamin (Multivitamin); Tobramycin; Robinul (Glycopyrronium Bromide); Albuterol; Qvar MDI (Beclometasone Dipropionate); Ipratropium Bromide; Calcitriol



Possible Keppra side effects in 3 year old female

Reported by a consumer/non-health professional from United States on 2011-11-03

Patient: 3 year old female, weighing 13.2 kg (29.0 pounds)

Reactions: Alopecia, Condition Aggravated, Convulsion

Drug(s) suspected as cause:
Increlex
    Dosage: 30 units (15 units, 2 in 1 d), subcutaneous
    Indication: Growth Hormone Deficiency
    Start date: 2011-03-01

Keppra
    Dosage: 6 ml (3 ml, 2 in 1 d), other
    Indication: Convulsion
    Start date: 2011-04-01

Dilantin
    Dosage: 4 ml (2 ml, 2 in 1 d), other
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-01

Other drugs received by patient: Phenobarbital TAB; Robinul (Glycopyrronium Bromide); Ipratropium Bromide; Ranititine (Ranitidine); Tobramycin; Qvar MD (Beclometasone Dipropionate); Calcitriol; Multi-Vitamin; Albuterol



Possible Keppra side effects in 3 year old female

Reported by a consumer/non-health professional from United States on 2011-10-18

Patient: 3 year old female, weighing 13.2 kg (29.0 pounds)

Reactions: Alopecia, Condition Aggravated, Convulsion

Drug(s) suspected as cause:
Dilantin
    Dosage: 4 ml (2 ml, 2 in 1 d), other
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-01

Increlex
    Dosage: 30 units (15 units, 2 in 1 d), subcutaneous
    Indication: Growth Hormone Deficiency
    Start date: 2011-03-01

Keppra
    Dosage: 6 ml (3 ml, 2 in 1 d), other
    Indication: Convulsion
    Start date: 2011-04-01

Other drugs received by patient: Qvar MDI (Beclometasone Dipropionate); Ranitdine (Ranitdine); Tobramycin; Phenobarbital TAB; Albuterol (Salbuterol); Robinul (Glycopyyrronium Bromide); Calcitriol; Ipratropium Bromide; Multivitamin (Multivitamin / 00831701 / )



Possible Keppra side effects in 24 year old female

Reported by a consumer/non-health professional from United States on 2011-10-12

Patient: 24 year old female

Reactions: Wrong Technique in Drug Usage Process, Condition Aggravated, Convulsion

Drug(s) suspected as cause:
Keppra
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-01

Suboxone
    Indication: Drug Dependence
    Start date: 2011-07-01

Topamax
    Dosage: takes 75 mg in am and 100 mg at bedtime
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-09-01

Other drugs received by patient: Phenobarbital TAB

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014